BIOMAT Database Logo BIOMAT Database Logo

Tamoxifen therapy in advanced breast cancer with positive estrogen receptors in postmenopausal women. 1982

A Bono, and G Fariselli, and I Bettoni, and M Alloisio, and N Nicoli, and S Di Pietro

UI MeSH Term Description Entries
D008593 Menopause The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age. Change of Life, Female
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013629 Tamoxifen One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM. ICI-46,474,ICI-46474,ICI-47699,Nolvadex,Novaldex,Soltamox,Tamoxifen Citrate,Tomaxithen,Zitazonium,Citrate, Tamoxifen,ICI 46,474,ICI 46474,ICI 47699,ICI46,474,ICI46474,ICI47699

Related Publications

A Bono, and G Fariselli, and I Bettoni, and M Alloisio, and N Nicoli, and S Di Pietro
Effect of tamoxifen treatment on estrogen metabolism in postmenopausal women with advanced breast cancer.
January 1982, Anticancer research,
A Bono, and G Fariselli, and I Bettoni, and M Alloisio, and N Nicoli, and S Di Pietro
Tamoxifen and prolactin secretion in postmenopausal women with advanced breast cancer.
January 1983, The Netherlands journal of medicine,
A Bono, and G Fariselli, and I Bettoni, and M Alloisio, and N Nicoli, and S Di Pietro
Next generation selective estrogen receptor degraders in postmenopausal women with advanced-stage hormone receptors-positive, HER2-negative breast cancer.
January 2024, Frontiers in oncology,
A Bono, and G Fariselli, and I Bettoni, and M Alloisio, and N Nicoli, and S Di Pietro
Adjuvant tamoxifen for pre- and postmenopausal women with estrogen receptor positive, node positive breast cancer: a randomized study.
January 1995, Breast cancer research and treatment,
A Bono, and G Fariselli, and I Bettoni, and M Alloisio, and N Nicoli, and S Di Pietro
Pharmacoeconomic analysis of adjuvant therapy with exemestane, anastrozole, letrozole or tamoxifen in postmenopausal women with operable and estrogen receptor-positive breast cancer.
May 2006, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico,
A Bono, and G Fariselli, and I Bettoni, and M Alloisio, and N Nicoli, and S Di Pietro
Estrogen therapy and breast cancer in postmenopausal women.
June 1980, Journal of the American Geriatrics Society,
A Bono, and G Fariselli, and I Bettoni, and M Alloisio, and N Nicoli, and S Di Pietro
Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen.
April 2008, Cancer,
A Bono, and G Fariselli, and I Bettoni, and M Alloisio, and N Nicoli, and S Di Pietro
Estrogen and progesterone receptors of adenomyosis in postmenopausal breast cancer patients treated with tamoxifen.
January 1998, Gynecologic and obstetric investigation,
A Bono, and G Fariselli, and I Bettoni, and M Alloisio, and N Nicoli, and S Di Pietro
Therapeutic effect of tamoxifen versus tamoxifen combined with medroxyprogesterone acetate in advanced breast cancer in postmenopausal women.
February 1979, Cancer treatment reports,
A Bono, and G Fariselli, and I Bettoni, and M Alloisio, and N Nicoli, and S Di Pietro
Optimising endocrine therapy in postmenopausal women with advanced breast cancer.
July 2018, Endocrine-related cancer,
Copied contents to your clipboard!